enGene Therapeutics (ENGN) Long-Term Investments (2022 - 2026)
enGene Therapeutics' Long-Term Investments was $26.71 million in fiscal Q2 2026 (quarter ended Apr 30, 2026), down 21.7% from $34.11 million a year earlier and down 27.0% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Long-Term Investments (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), Long-Term Investments at enGene Therapeutics came in at $8.52 million, down 85.7% from FY2024.
- In earlier fiscal years, Long-Term Investments was $59.53 million in FY2024.
- Quarterly Long-Term Investments has moved between $8.52 million (fiscal Q4 2025) and $59.53 million (fiscal Q4 2024) over five years.
- Compared with a year earlier, Long-Term Investments has declined for three straight quarters.
- Per Business Quant data, ENGN's Long-Term Investments in the three fiscal quarters before Q2 2026 was $36.6 million (Q1 2026), $8.52 million (Q4 2025) and $23.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.01 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | - |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 387.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 1.60 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 63.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 268.00 Mn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 1.45 Bn |
| 10 | enGene Therapeutics | 161.50 Mn | -832.97 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 26.71 Mn |
| Jan 31, 2026 | 36.60 Mn |
| Oct 31, 2025 | 8.52 Mn |
| Jul 31, 2025 | 23.01 Mn |
| Apr 30, 2025 | 34.11 Mn |
| Jan 31, 2025 | 58.98 Mn |
| Oct 31, 2024 | 59.53 Mn |
| Jul 31, 2024 | 75,000.00 |
| Apr 30, 2024 | 75,000.00 |
| Jan 31, 2024 | 79,000.00 |
| Oct 31, 2023 | 76,000.00 |
| Oct 31, 2022 | 74,000.00 |
API Access
enGene Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();